baber/WOPTO huggingface dataset:
Patent AT-E238654-T1 (AT)
Inventor: LARSEN JESPER KRISTOFFER
IPC: A01K1/10
Filed: 1999-12-23
Granted: 2003-05-15
Abstract: An arrangement for feeding of animals, in particular pigs and sows, kept in a free-range herd, comprises a carrousel divided into a number of feeding enclosures so that a large number of animals may be automatically and individually fed. A common inlet with a registration system leads to the feeding enclosures of the carrousel. The animals are identified, weighed and may optionally have the temperature, the thickness of the fat layer and an image recorded. All data are stored in a computer system controlling the operation of the arrangement, including separation of animals from the herd. The computer system optionally being connected to a remote, central computer for surveillance of its operation and of the individual animal.
Patent AT-E245410-T1 (AT)
Inventor: WOHLRAB WOLFGANG
IPC: C12P19/26
Filed: 1999-12-22
Granted: 2003-08-15
Abstract: The invention relates to an agent for the treatment, prophylaxis and metaphylaxis of functional and structural disorders of the skin caused by external factors. The agent contains a hyaluronic acid partially digested with a microbiological hyaluronate lyase. The hyaluronic acid fragment mixture is incorporated in different galenic formulations to which other hydrophilic and/or lipophilic active substances and/or auxiliary substances can be added. Fields of application of the invention in human and veterinary medicine relate to the treatment and/or the prophylaxis of skin damage caused by environmental factors including UV, dry skin conditions and skin ageing.
Patent AT-E300204-T1 (AT)
Inventor: MATHIEZ JEAN-LOUIS
IPC: A45C13/00
Filed: 1999-11-22
Granted: 2005-08-15
Abstract: One embodiment of the present invention includes a cover (6) for a packaging for a cosmetic and/or a pharmaceutical composition.The cover (6) comprises means of attachment on a container of the packaging and a sealing wall for sealing an opening of the container (1). The sealing wall is a flexible wall that is elastically deformable by a difference in pressure exerted on its two main sides.
Patent DE-03734034-T1 (DE)
Title: Integrierte dreifunktions-hydraulikventilbaugruppe
Inventor: FENNY CARLOS A
IPC: B64C27/28
Filed: 2003-05-16
Abstract: Integrierte
Dreifunktions-Hydraulikventilbaugruppe, umfassend:  einen Verteiler;  eine
Primärspule,
die in dem Verteiler angeordnet ist;  eine Hilfsspule, die in
dem Verteiler angeordnet ist und betriebsbereit mit der Primärspule verbunden
ist;  mindestens eine Feder zum Positionieren der Primärspule und
der Hilfsspule; und  ein Steuersystem, das von dem Verteiler
getragen wird, zum Steuern der Primärspule und der Hilfsspule;  wobei
die Primärspule
und die Hilfsspule arbeiten, um eine Überlaufventilfunktion, eine
Druckentlastungsventilfunktion und eine Deltadruckwandlerfunktion
bereitzustellen.
Patent DE-10295375-T1 (DE)
Inventor: ADAHAN CARMELI
IPC: F04B35/01
Filed: 2002-08-12
Abstract: A vacuum pump capable of pumping solid, liquid and gas, or any combination thereof, including a drive (40) and a manually disengageable pumping system connected thereto. The pumping system is composed of a two- or three-chambered canister (1, 18, 21) within which solids, liquids, and gases can be separated from one another. A highly flexible diaphragm (24) attached to the canister and sealed against it circumferentially, facilitates this separation, when reciprocating and pumping. The components of the pumping system are designed to be disposable, and the two- or three-chambered canister provides for a highly efficient pumping system that is significantly smaller in size than those previously known. The pump is particularly useful for medical applications.
Patent DE-19211738-T1 (DE)
Title: Neuromodulationssystem
Inventor: SCHELTIENNE MATHIEU
IPC: A61N1/36
Filed: 2019-11-27
Abstract: Neuromodulationssystem (10, 110), aufweisend- mindestens ein Eingabemodul (12, 112) zum Eingeben eines geplanten Neuromodulationsereignisses oder eine Serie von Neuromodulationsereignissen,- mindestens ein Analysemodul (14, 114) zum Analysieren eines Neuromodulationsereignisses oder einer Serie von Neuromodulationsereignissen, wobei das Analysemodul (14, 114) und das Eingabemodul (12, 112) derart verbunden sind, dass das Eingabemodul (12, 112) dafür ausgelegt ist, das geplante Neuromodulationsereignis oder eine Serie von Neuromodulationsereignissen an das Analysemodul (14, 114) weiterzuleiten, und wobei das Analysemodul (14, 114) dafür ausgelegt ist, das geplante Neuromodulationsereignis oder eine Serie von Neuromodulationsereignissen hinsichtlich eines oder mehrerer möglicher Neuromodulationskonflikte zu analysieren.
Patent DE-372628-T1 (DE)
IPC: C10N40/32
Filed: 1989-11-29
Abstract: The invention relates to an aqueous lubricant solution based in part on a particular group of fatty alkyl amines, which aqueous solution is especially suitable for use as a belt lubricant for the lubrication of conveyor belts for bottles. The aqueous lubricant solutions in accordance with the present invention exhibit excellent clouding behaviour and very good gliding action.
Patent DE-1044477-T1 (DE)
Inventor: NARDI C
IPC: C01B31/04
Filed: 1999-01-06
Abstract: An electrochemical cell having a cathode containing an expanded graphite as an electrically conductive carbon material. To provide enhanced service performance in the cell, the expanded graphite has a kerosene absorption in the range of 2.2 to 3.5 ml/g, an average particle size of 17 to 32 micrometers, a d90 value of 40 to 85 micrometers, and an average surface area-to-mass ratio of at least 18 m<2>/g. A method is also provided for determining an optimum expanded graphite including the steps of measuring physical characteristics of the expanded graphite determining the performance of a cell containing the expanded graphite in the positive electrode, and determining the optimum expanded graphite for use in the cell.
Patent ES-2239924-T1 (ES)
Inventor: WINCHELL HARRY S
IPC: A61K6/00
Filed: 2001-02-14
Abstract: This invention involves the use of a class of compounds with chelation affinity and selectivity for first transition series elements. Application or administration of the free or conjugated compound, or physiological salts of the free or conjugated compound, results in decrease of the bioavailability and/or chemical action of first transition series elements. These characteristics make such compounds useful in cosmetics and personal care products to decrease odor arising from microbial growth on body surfaces and in body cavities, decrease microbial growth on teeth, plaque, and gums that cause tooth decay and gum disease, inhibition of oxidative damage to the skin, inhibition of enzymatic action of metalloenzymes dependent on first transition series elements, and inhibition of reperfusion injury.
Patent ES-2235681-T1 (ES)
Inventor: PEARSON STEVEN FORBES
IPC: F25B1/00
Filed: 2004-04-22
Abstract: A transcritical vapour compression refrigeration apparatus which comprises a compressor (1), a gas cooler (3), an economiser (7), an evaporator (9) and a refrigerant; the refrigerant being compressed in the compressor, heat being rejected from the compressed refrigerant at supercritical pressure in the gas cooler, the cooled compressed refrigerant being then expanded in a first stage to first temperature and pressure conditions in the economiser and then expanded in a second stage to second temperature and pressure conditions; a stream of refrigerant from the economiser at said first temperature and pressure conditions then being compressed in a first stream in the compressor; refrigerant at said second temperature and pressure conditions absorbing heat in the evaporator and then being compressed in a separate second stream in the compressor; 
said first and second compressed streams then being combined before passing to the gas cooler; or the first and second compressed streams passing through separate gas coolers before being combined.  Preferably, the ratio of swept volume of the second stream to the first stream is in the ration of 1.1 - 11 to one. A preferred refrigerant is carbon dioxide.
Patent ES-2499690-T1 (ES)
Title: Conector de fibra óptica
Inventor: MCDONALD JOHN A
IPC: G02B6/44
Filed: 2002-09-27
Abstract: Un enchufe de fibra óptica (10), que comprende un conector de fibra óptica (16) que comprende una carcasa de conector (18) y una contera de enchufe (20) dispuesta, al menos parcialmente, dentro de la carcasa de conector (18) y apta para ser montada sobre una porción extrema de al menos una fibra óptica; y un cuerpo de enchufe (14) que se extiende en dirección longitudinal entre un primer extremo (48) y un segundo extremo (50) y que tiene una cubierta (56) próxima al primer extremo (48) de la misma, en el que el primer extremo (48) está opuesto al segundo extremo (50), definiendo la cubierta (56) al menos un orificio (58), extendiéndose el al menos un orificio (58) en dirección longitudinal desde al menos una porción media de la cubierta (56) hasta el primer extremo (48) del cuerpo de enchufe (14), en el que el conector de fibra óptica (16) está dispuesto dentro del cuerpo del enchufe (14), de tal manera que la contera de enchufe (20) es accesible dentro de la cubierta (56) a través del primer extremo (48) del cuerpo del enchufe (14).
Patent ES-2148131-T1 (ES)
Inventor: STRANNER SIEGFRIED
IPC: F41H5/26
Filed: 1999-10-21
Abstract: The armoured glass comprises a frame which holds a number of coated glass sheets (1,2) in laminar form. At least one glass sheet (1) has a section (12) which protrudes beyond the other sheets to form a step. The protruding section is located on the frame. The surface over the stepped area has a plastics holder (10) which prevents splintering. The holder is preferably made of polycarbonate.
Patent CY-1107544-T1 (CY)
Inventor: AMSELLEM MAURICE
IPC: A01G29/00
Filed: 2006-12-05
Abstract: A fitting consisting of a part made of injected plastic for connecting a water tank and a hollow cone made of porous ceramics, so as to produce a device for dispensing water individually to plants, in particular potted plants, proximate to their roots, and in predetermined amount, comprising three coaxial parts; a disc-shape intermediate part with a central hole; a part consisting of one or two cylinders, arranged on one side of the disc and designed to be permanently fixed to the cone; a part consisting of one or two cylinders bearing a thread on the inner surfaces, arranged on the other side of the disc and capable of receiving a bottle removably screwed.
Patent CY-1107821-T1 (CY)
Inventor: LENTING PETRUS JOHANNES
IPC: C07K14/705
Filed: 2007-12-04
Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
Patent CY-1111174-T1 (CY)
Inventor: WEINSCHENK TONI
IPC: A61K39/00
Filed: 2010-11-03
Abstract: Tumor-associated peptides (I) having any of 79 sequences, reproduced, are new. (I) can bind to a Class I molecule of the human major histocompatibility complex (MHC). Independent claims are also included for the following: (1) nucleic acid (II) that encodes (I); (2) vector that contains (II); and (3) cell modified to express (I), by incorporation of (II) or the vector of (2). ACTIVITY : Cytostatic. MECHANISM OF ACTION : Vaccine; induction of cytotoxic T lymphocytes (CTL). Dendritic cells (0.5 million) were isolated from peripheral blood and incubated with peptide (1) at 50 mu g/ml for 2 hours, then washed and incubated with 2.5 million autologous peripheral blood mononuclear cells (PBMC) for 7 days. The cells were restimulated with interleukin-2 (1 ng/ml) on days 1, 3 and 5, then cytotoxicity tested against various cancer cells at effector:target ratio 30:1, in a standard 51chromium release assay. Typical specific lysis scores were over 30% for HCT 116 stomach cancer cells; over 60% for A498 renal cancer cells; about 40% for MEL1479 melanoma and about 50% for MCF-7 breast cancer cells. Tyr-Val-Asp-Pro-Val-Ile-Thr-Ser-Ile (1).
Patent CY-1111158-T1 (CY)
Inventor: CHRISTENSEN MARTIN
IPC: B64D11/06
Filed: 2011-02-02
Abstract: The present invention concerns a mounting device for fastening a chair or seat to a groove (41), said groove comprising engagement means (45), where the mounting device comprises locking means (20) prepared for entering the groove and for being moved along the longitudinal axis of the groove; said locking means having means (23) for engaging with the engagement means (45) of the groove. The mounting device further comprises positioning means (30) for finding a position of the mounting device where the locking means will be able to engage with the engagement means of the groove. The mounting device comprises a first cam (22) for controlling the engagement and disengagement of the locking means with said engagement means; a second cam (32) for switching the positioning means into an active position, where the positioning means extend into the groove in selected parts (46) thereof; and one shaft (5) for rotating both the first and the second cam, said shaft being, by a rotational movement, able to adjust the mounting device between at least three modes: 
1) the positioning means is passive and the locking means are disengaged, 
2) the positioning means is active and the locking means are disengaged, 
3) the locking means are engaged with the engagement means. 
The invention also concerns a method for mounting a mounting device according to the invention.
Patent CY-1111577-T1 (CY)
Inventor: COMEAU MICHAEL R
IPC: A61P43/00
Filed: 2011-06-21
Abstract: The invention provides methods and compositions for reducing or preventing fibrosis in a subject suffering from a fibrotic disorder by administering a therapeutically effective amount of at least one antagonist to the cytokine thymic stromal lymphopoietin to the subject. In one embodiment, the methods and compositions further comprise administering at least one additional antagonist to an additional profibrotic cytokine, growth factor or chemokine.
Patent CY-1112921-T1 (CY)
Title: Ενεργοποιητες γλυκοκινασης πυρρολιδινονης
Inventor: BERTHEL STEVEN JOSEPH
IPC: C07F7/18
Filed: 2012-07-24
Abstract: Στο παρόν παρέχονται οι ενώσεις του τύπου (Ι): όπου τα Χ, R1, R2 και R3 είναι όπως ορίζονται στην περιγραφή, καθώς και τα φαρμακευτικώς αποδεκτά άλατα αυτών. Αυτές οι ενώσεις και οι φαρμακευτικές συνθέσεις που τις περιέχουν είναι χρήσιμες για τη θεραπευτική αντιμετώπιση μεταβολικών νόσων και διαταραχών όπως, για παράδειγμα, ο σακχαρώδης διαβήτης τύπου II.
Patent CY-1117766-T1 (CY)
Title: Αντιβακτηριδιακα παραγωγα κινολινης
Inventor: GUILLEMONT JÉRÔME EMILE GEORGES
IPC: C07D401/04
Filed: 2016-06-08
Abstract: Η παρούσα εφεύρεση αναφέρεται σε νέα παράγωγα υποκατεστημένης κινολίνης, σύμφωνα με τον γενικό τύπο (la) ή τον τύπο (lb): συμπεριλαμβανομένων οποιωνδήποτε στερεοχημικώς ισομερών μορφών αυτών, ενός N-οξειδίου αυτών, ενός φαρμακευτικά αποδεκτού άλατος αυτών, ή ενός επιδιαλυτωμένου άλατος αυτών. Οι αξιούμενες ενώσεις είναι χρήσιμες για την θεραπεία μίας βακτηριδιακής μόλυνσης. Επίσης αξιώνεται μία σύνθεση που περιλαμβάνει έναν φαρμακευτικά αποδεκτό φορέα και, ως ενεργό συστατικό, μία θεραπευτικά αποτελεσματική ποσότητα των αξιουμένων ενώσεων, η χρήση των αξιουμένων ενώσεων ή των σύνθετων ιόντων για την παρασκευή ενός φαρμακευτικού μέσου για την θεραπεία μίας βακτηριδιακής μόλυνσης και μία διεργασία για την παρασκευή των αξιουμένων ενώσεων.
Patent CY-1121284-T1 (CY)
Inventor: SHUE YOUE-KONG
IPC: A61K45/06
Filed: 2019-02-28
Abstract: The invention relates to a compound having formula (II), a pharmaceutical composition comprising the compound and the compound for use in treating or preventing a disease in a patient caused by the presence of  Clostridium difficile,  methicillin-resistant  Staphylococcus aureus  (MRSA) or vancomycin-resistant enterococci (VRE).
Patent HR-P20090395-T1 (HR)
Inventor: POUZET PASCALE
IPC: C07D495/04
Filed: 2009-07-10
Abstract: Spojevi, naznačeni time, da su formule 1, gdje X označava O, S, SO ili SO2;R1 označava H, C1-6-alkil, C2-6-alkenil, C2-6-alkinil, C6-10-aril ili C6-10-aril-C1-6-alkilen, C5-10-heteroaril-C1-6-alkilen; R2 označava H ili po izboru mono- ili poli- supstituiranu skupinu izabranu iz skupine koju čine C1-6-alkil, C2-6-alkenil, C2-6-alkinil, po izboru mono- ili poli- premošteni mono- ili bi- ciklički C3-10-cikloalkil, C6-10-aril, aromatski ili ne-aromatski, heterociklički C3-10 prsten, biciklički prsten i C6-10-aril povezan na C3-10 heterocikl; ili NR1R2 zajedno označavaju heterociklički prsten koji je po izboru supstituiran s jednom ili više skupina izabranih iz skupine koju čine C1-4-alkil, C2-6-alkenil, C2-6-alkinil, C1-6-alkanol ravnog ili razgranatog lanca i okso; R3 označava mono- ili poli- supstituiranu skupinu izabranu iz skupine koju čine heterociklički C6-10 prsten, C3-7-cikloalkil, C6-10-aril-C1-6-alkilen, C5-10-heteroaril-C1-6-alkilen, povezani biciklički prsten koji može po izboru sadržavati 1-4 heteroatoma izabrana nezavisno jedan od drugog između N, O, S, ili R3 označava po izboru supstituirani fenil; ili R3 označava skupinu COR3.7, COCH2R3.8, CONHR3.8 ili SO2R3.8;gdjeR3.7 označava H, C1-6-alkil, C2-6-alkenil, C2-6-alkinil ili C6-10-aril; R3.8 označava C1-6-alkil, C2-6-alkenil, C2-6-alkinil, C3-7-cikloalkil ili skupinu izabranu iz skupine koju čine C6-10-aril, heterociklički C3-10 prsten i biciklički prsten koji je po izboru supstituiran s jednom ili više skupina izabranih iz skupine koju čine C1-6-alkil, C2-6-alkenil, C2-6-alkinil, halogen, NR3.8.1R3.8.2, C6-10-aril i heterociklički C3-10 prsten; gdjeR3.8.1 označava H, C1-6-alkil, C2-6-alkenil ili C2-6-alkinil; R3.8.2 označava H, C1-6-alkil, C2-6-alkenil ili C2-6-alkinil; R4 označava H, C1-4-alkil, C2-4-alkenil, C2-4-alkinil ili okso; R5 označava H, C1-4-alkil, C2-4-alkenil ili C2-4-alkinil; R6 označava H, C1-4-alkil, C2-4-alkenil ili C2-4-alkinil; R7 označava H, C1-4-alkil, C2-4-alkenil, C2-4-alkinil, C6-10-aril ili OH; R8 označava H, C1-4-alkil, C2-4-alkenil, C2-4-alkinil, C6-10-aril ili OH; iliR7 i R8 skupa formiraju okso; i njihove farmakološki prihvatljive soli i njihovi dijastereoizomeri, enantiomeri, racemati, hidrati ili solvati. Patent sadrži još 28 patentnih zahtjeva.
Patent HR-P20110962-T1 (HR)
Inventor: DAVIES AUDREY
IPC: C07D401/12
Filed: 2011-12-21
Abstract: Spoj formule (I),naznačen time, što R1 i R2 se nezavisno biraju između vodika, halo, nitro, cijano, hidroksi, trifluorometoksi, amino, karboksi, karbamoil, merkapto, sulfamoil, C1-6alkil, C2-6alkenil, C2-6alkinil, C1-6alkoksi, C1-6alkanoil, C1-6alkanoiloksi, N-(C1-6alkil)amino, N,N-(C1-6alkil)2amino, C1-6alkanoilamino, N-(C1-6alkil)karbamoil, N,N-(C1-6alkil)2karbamoil, C1-6alkilS(O)a, pri čemu a je 0 do 2, C1-6alkoksikarbonil, N-(C1-6alkil)sulfamoil, N,N-(C1-6alkil)2sulfamoil, C1-6alkilsulfonilamino, karbociklil ili heterociklil; pri čemu R1 i R2 nezavisno jedan od drugoga mogu opcijski biti supstituirani na ugljiku jednim ili više R6; i pri čemu ako spomenuti heterociklil sadrži -NH- komponentu, taj dušik može biti opcijski supstituiran grupom koja se bira od R7; jedan od X1, X2, X3 i X4 je =N-, druga tri se nezavisno biraju između =CR8-, =CR9- i =CR10-;R3 je vodik ili opcijski supstituirani C1-6alkil; pri čemu se spomenuti opcijski supstituenti biraju između jednog ili više R11; R4 i R34 se nezavisno biraju između vodika, halo, nitro, cijano, hidroksi, trifluorometoksi, amino, karboksi, karbamoil, merkapto, sulfamoil, C1-6alkil, C2-6alkenil, C2-6alkinil, C1-6alkoksi, C1-6alkanoil, C1-6alkanoiloksi, N-(C1-6alkil)amino, N,N-(C1-6alkil)2amino, C1-6alkanoilamino, N-(C1-6alkil)karbamoil, N,N-(C1-6alkil)2karbamoil, C1-6alkilS(O)a, pri čemu a je 0 do 2, C1-6alkoksikarbonil, N-(C1-6alkil)sulfamoil, N,N-(C1-6alkil)2sulfamoil, C1-6alkilsulfonilamino, karbociklil ili heterociklil; pri čemu R4 i R34 mogu biti nezavisno opcijski supstituirani na ugljiku jednim ili više R12; i pri čemu ako spomenuti heterociklil sadrži -NH- komponentu, taj dušik može biti opcijski supstituiran grupom koja se bira od R13; A je direktna veza ili C1-2alkilen; pri čemu spomenuti C1-2alkilen može biti opcijski supstituiran jednim ili više R14;Prsten C je karbociklil ili heterociklil; pri čemu ako spomenuti heterociklil sadrži -NH- komponentu, taj dušik može biti opcijski supstituiran grupom koja se bira od R15; R5 se bira između halo, nitro, cijano, hidroksi, trifluorometoksi, amino, karboksi, karbamoil, merkapto, sulfamoil, C1-6alkil, C2-6alkenil, C2-6alkinil, C1-6alkoksi, C1-6alkanoil, C1-6alkanoiloksi, N-(C1-6alkil)amino, N,N-(C1-6alkil)2amino, C1-6alkanoilamino, N-(C1-6alkil)karbamoil, N,N-(C1-6alkil)2karbamoil, C1-6alkilS(O)a, pri čemu a je 0 do 2, C1-6alkoksikarbonil, N-(C1-6alkil)sulfamoil, N,N-(C1-6alkil)2sulfamoil, C1-6alkilsulfonilamino, karbociklil-R37 ili heterociklil-R38; pri čemu R5 može biti opcijski supstituiran na ugljiku jednim ili više R16; i pri čemu ako spomenuti heterociklil sadrži -NH- komponentu, taj dušik može biti opcijski supstituiran grupom koja se bira od R17;n je 0, 1, 2 ili 3; pri čemu vrijednosti R5 mogu biti iste ili različite; R8, R9 i R10 se nezavisno biraju između vodika, fluoro i cijano; R6, R11, R12, R14 i R16 se nezavisno biraju između halo, nitro, cijano, hidroksi, trifluorometoksi, amino, karboksi, karbamoil, merkapto, sulfamoil, C1-6alkil
Patent HR-P20120414-T1 (HR)
Title: Foil packaging
Inventor: ELIANE PIERRON
IPC: B32B15/08
Filed: 2012-05-15
Abstract: The foil packaging for soft food mass e.g.candy, comprises a container foil with a hot-seal layer formed to an open container (13), and a cover foil locking the container with a cover (16, 20) sealed against the hot-seal layer of the container foil. The container foil and the cover foil are constructed in multilayered manner and the layer is an optional single side pre-lacquered aluminum foil and/or printed- and over lacquered aluminum foil. The aluminum foil of the container foil and the cover foil is coated with a polymer. The foil packaging for soft food mass e.g.candy, comprises a container foil with a hot-seal layer formed to an open container (13), and a cover foil locking the container with a cover (16, 20) sealed against the hot-seal layer of the container foil. The container foil and the cover foil are constructed in multilayered manner and the layer is an optional single side pre-lacquered aluminum foil and/or printed- and over lacquered aluminum foil. The aluminum foil of the container foil and the cover foil is coated with a polymer. The hot-seal layer is arranged on the polymer layer. A corrosion protective layer consisting of polymer is arranged alternatively on the aluminum foil of the cover foil at the seal side of the polymer optionally coated with the hot-seal layer and on the another side of the aluminum foil, or the aluminum foil of the cover foil is arranged on the seal side coated with hot-seal layer and the polymer layer coated with the hot-seal layer is arranged on the another side of the aluminum foil. The aluminum foil of the container foil and the cover foil has a thickness of 6-12 mu m and is coated with polymer with a specific weight per area of 2-8 g/m 2>. The polymer is ionomer. The hot-seal layer is a low-temperature sealing wax.
Patent SI-2409707-T1 (SI)
Title: Polymer-based sustained release device
Inventor: WRIGHT STEVEN G
IPC: A61K9/00
Filed: 2004-04-15
Abstract: This invention relates to compositions for the sustained release of biologically active polypeptides, and methods of forming and using said compositions, for the sustained release of biologically active polypeptides. The sustained release compositions of this invention comprise a biocompatible polymer having dispersed therein, a biologically active polypeptide and a sugar.